Noopept as a nootropic: what the science actually supports

What did @lowkey_fish_ actually say?

The creator made a stack of claims about Noopept, which they called "New PEP" throughout the video. The short version: Noopept boosts critical thinking, memory encoding and recall, verbal fluidity, and alpha and beta brain wave activity. They also said it produces stimulant-like effects without the "wired" feeling, functions as a "study drug" and a "conversation drug," and helps users enter a "flow state." They also noted it does not appear in blood tests and is legal and unregulated in most of the world.

One factual claim worth flagging immediately: the creator said Noopept "is given out as a prescription in Russia." That part is true. Noopept (omberacetam) is a registered pharmaceutical in Russia, developed by the Zakusov Institute of Pharmacology. The rest of the claims get more complicated.

Does the science back this up?

Partially, but mostly in animal models and small Russian clinical trials, which is a significant caveat. The human evidence for Noopept as a cognitive enhancer in healthy adults is thin to nonexistent.

Noopept does appear to modulate NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor) expression in rodent studies. Ostrovskaya et al. (2007, Bulletin of Experimental Biology and Medicine) showed neuroprotective effects in rat models of Alzheimer's-type pathology. Gudasheva et al. (1997, European Journal of Medicinal Chemistry) described its mechanism as enhancing acetylcholine neurotransmission, which is plausible for memory-adjacent effects.

The claim about boosting "alpha and beta brain wave activity" does have a small basis. A 2011 study by Kondratenko et al. published in Russian journal Eksperimental'naya i Klinicheskaya Farmakologiya found EEG changes in alpha and beta bands after Noopept administration. But this was a small, non-peer-reviewed-by-Western-standards study, and EEG band changes do not automatically translate to better cognition in a meaningful way.

The "flow state" and "conversation drug" framing? There is no clinical evidence for either. That is speculation dressed up as pharmacology.

What did they get wrong (or right)?

They got the legal and regulatory framing mostly right. Noopept is not scheduled in the United States, not FDA-approved, and technically available as a research compound. It does not show up on standard SAMHSA drug panels. Those are accurate statements.

They got the memory mechanism directionally right. Noopept is thought to work on AMPA receptor potentiation and cholinergic signaling, which relates to encoding, consolidation, and retrieval. Framing it as helping you "develop a memory, retain the memory, and then recall that memory" is oversimplified but not factually wrong in spirit.

What they got wrong is the confidence level. Describing Noopept as "highly effective" as a study drug is not supported by human clinical trial data. Every robust study on Noopept has been conducted in cognitively impaired populations, mostly elderly patients with mild cognitive impairment. Guekht et al. (2017, Zhurnal Nevrologii i Psikhiatrii) found modest benefits in patients recovering from ischemic stroke. That does not mean it sharpens the cognition of a healthy 22-year-old cramming for finals.

The "verbal fluidity" claim is essentially unsubstantiated in peer-reviewed literature. Anecdotal. The creator should have said so.

What should you actually know?

Noopept sits in a gray zone that makes it genuinely hard to evaluate. It is not a supplement with decades of safety data. It is not a prescription drug in the US with an FDA-reviewed risk profile. It is a research compound with a real pharmacological mechanism, limited human trials, and zero long-term safety data in healthy populations.

The absence from drug tests the creator mentions is accurate, but worth contextualizing differently than they did. It does not mean Noopept is safe. It means it has not been included in standard panels because it is not a controlled substance. Those are different things.

If you are considering any nootropic compound, the conversation should happen with a clinician who understands your full medical history, not based on a 60-second TikTok. Some compounds in this category interact with medications, particularly antidepressants and anxiolytics. Noopept specifically has shown some anxiolytic-like properties in animal models, which raises questions about interactions that nobody has studied in humans at scale.

The "smart drug" framing is also worth questioning on principle. Cognitive enhancement in healthy adults remains one of the least-supported ideas in all of neuropharmacology. That does not mean nothing works. It means the bar for evidence should be higher than it is in most nootropic content online.